MedDataX Logo

Quality Project to Evaluate and Validate the FAST-O Rating Scale

NCT ID: NCT00913731

Last Updated: 2009-10-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

111 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-05-31

Study Completion Date

2009-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this project is to test the reliability of the FAST-O Rating Scale in patients at acute wards or psychiatric intensive care units.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Psychotic Symptoms

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Psychotic symptom assessments Observational assessments of patients with acute psychotic symptoms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

psychotic patients

psychotic patients, acute ward, symptom rating scale.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with acute psychotic symptoms attending the acute ward or psychiatric intensive care unit

Exclusion Criteria

* Not applicable
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

AstraZeneca

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eva Dencker Vansvik

Role: STUDY_DIRECTOR

Medical Department

Eva Lindström

Role: PRINCIPAL_INVESTIGATOR

Rättspsyk, UMAS, Malmö

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

Helsingborg, , Sweden

Site Status

Research Site

Kristianstad, , Sweden

Site Status

Research Site

Lund, , Sweden

Site Status

Research Site

Malmo, , Sweden

Site Status

Research Site

Ystad, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIS-NSE-DUM-2008/1

Identifier Type: -

Identifier Source: org_study_id